Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
We’re thrilled to announce that CluePoints is now offering a complimentary Risk-Based Monitoring strategy Check-up and...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has...
- Press Release
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live!...
- Press Release
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that...
- Press Release
Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this...
- Press Release
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership...
- Press Release
Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA –...
- Press Release
Partnership will combine CluePoints’ Risk-Based Monitoring Software with Widler & Schiemann’s Consultancy Services Cambridge, MA –...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials,...
- Press Release
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS,...
- Press Release
For well over a year now, the clinical research community has been hard at work to...
- Press Release
Risk-Based Monitoring is the future of clinical trials – but despite significant advances in recent years,...
- Press Release
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The...
- Press Release
In the world of clinical trials, if it isn’t documented, it didn’t happen. It’s a philosophy...
- Press Release
It has never been more important for the clinical trial community to come together and share...
- Press Release
King of Prussia, PA – January 19, 2021: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 8th, 2020: CluePoints, the premier provider of Central Statistical Monitoring,...
- Press Release
LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a...
- Press Release
Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection King of Prussia, PA: CluePoints, the...
- Press Release
On July 28, CluePoints is teaming up with DIA for a webinar to explore how the...
- Press Release
Personalizing the Power of Statistical Analysis and Data Visualization King of Prussia, PA: CluePoints, the premier...
- Featured Article
Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage...
Source: OutsourcingPharma
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
CluePoints is continuing to invest in artificial intelligence (AI) and machine learning (ML) they say they...
Source: Outsourcing Pharma
- Featured Article
With the clinical trial landscape continuing to evolve and adapt, OSP took the opportunity to speak...
Source: Outsourcing Pharma
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials